(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 8.61% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.94%.
Caredx's revenue in 2026 is $497,396,000.On average, 10 Wall Street analysts forecast CDNA's revenue for 2026 to be $27,927,541,615, with the lowest CDNA revenue forecast at $25,493,759,767, and the highest CDNA revenue forecast at $28,976,821,051. On average, 10 Wall Street analysts forecast CDNA's revenue for 2027 to be $30,626,139,104, with the lowest CDNA revenue forecast at $29,015,702,713, and the highest CDNA revenue forecast at $32,550,255,927.
In 2028, CDNA is forecast to generate $33,949,995,746 in revenue, with the lowest revenue forecast at $29,257,924,956 and the highest revenue forecast at $37,250,733,563.